PFIZER INC Deferred Income Taxes and Other Assets, Noncurrent
PFIZER INC (PFE) had Deferred Income Taxes and Other Assets, Noncurrent of $4.98 billion as of 2013-09-29, per its 10-Q filed 2013-11-08.
Discontinued › Notes › Deferred Income Taxes and Other Assets
us-gaap:DeferredIncomeTaxesAndOtherAssetsNoncurrent · last filed 2013-11-08
- 2013-09-29: Deferred Income Taxes and Other Assets, Noncurrent $4.98B.
- 2013-06-30: Deferred Income Taxes and Other Assets, Noncurrent $5.14B.
- 2013-03-31: Deferred Income Taxes and Other Assets, Noncurrent $5.43B.
- 2012-12-31: Deferred Income Taxes and Other Assets, Noncurrent $4.80B; Deferred Income Taxes and Other Assets, Noncurrent as first filed $5.09B.
| Period end | Deferred Income Taxes and Other Assets, Noncurrent | Deferred Income Taxes and Other Assets, Noncurrent as first filed |
|---|---|---|
| 2013-09-29 | $4.98B 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $5.14B 10-Q · filed 2013-08-09 | |
| 2013-03-31 | $5.43B 10-Q · filed 2013-05-10 | |
| 2012-12-31 | $4.80B 10-Q · filed 2013-11-08 | $5.09B 10-K · filed 2013-02-28 |
| 2012-09-30 | $5.86B 10-Q · filed 2012-11-09 | |
| 2012-07-01 | $5.81B 10-Q · filed 2012-08-09 | |
| 2012-04-01 | $5.94B 10-Q · filed 2012-05-10 | |
| 2011-12-31 | $5.70B 10-K · filed 2013-02-28 | $4.98B 10-K · filed 2012-02-28 |
| 2011-10-02 | $5.21B 10-Q · filed 2011-11-10 | |
| 2011-07-03 | $4.76B 10-Q · filed 2011-08-11 | |
| 2011-04-03 | $4.72B 10-Q · filed 2011-05-12 | |
| 2010-12-31 | $4.13B 10-K · filed 2012-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |